Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study (Q46804734)

25 December 2017

title

Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study (English)

1 reference

25 December 2017

1 reference

3

1 reference

25 December 2017

Stephen J Wood

object named as

Stephen J Wood

2

0 references

Christos Pantelis

9

object named as

Christos Pantelis

1 reference

25 December 2017

Patrick McGorry

10

object named as

Patrick D McGorry

1 reference

25 December 2017

author name string

Gregor E Berger

1

1 reference

25 December 2017

Tina M Proffitt

4

1 reference

25 December 2017

Mirabel McConchie

5

1 reference

25 December 2017

G Paul Amminger

6

1 reference

25 December 2017

Graeme D Jackson

7

1 reference

25 December 2017

Dennis Velakoulis

8

1 reference

25 December 2017

language of work or name

English

0 references

publication date

16 January 2008

1 reference

25 December 2017

published in

Neuropsychopharmacology

1 reference

25 December 2017

volume

33

1 reference

25 December 2017

page(s)

2467-2473

1 reference

25 December 2017

issue

10

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301628

exact match

0 references

cites work

Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

Altered glutathione redox state in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Lipid signaling in neural plasticity, brain repair, and neuroprotection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Bioactive lipids in excitatory neurotransmission and neuronal plasticity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Bioactive lipids in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Proton magnetic resonance spectroscopy in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Omega-3 fatty acids for depression in pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Metabolism and functions of glutathione in brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Glutathione pathways in the brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

The effects of eicosapentaenoic acid in tardive dyskinesia: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Major depression is associated with lower omega-3 fatty acid levels in patients with recent acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Differential effect of nitric oxide on glutathione metabolism and mitochondrial function in astrocytes and neurones: implications for neuroprotection/neurodegeneration?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Co-culture of neurones with glutathione deficient astrocytes leads to increased neuronal susceptibility to nitric oxide and increased glutamate-cysteine ligase activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behaviour of young adult prisoners. Randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Dopamine-induced oxidative stress in neurons with glutathione deficit: implication for schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Effects of eicosapentaenoic acid and docosahexaenoic acid on plasma membrane fluidity of aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Intercellular metabolic compartmentation in the brain: past, present and future

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Astrocytic control of glutamatergic activity: astrocytes as stars of the show

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Omega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Membrane abnormalities in the psychoses and affective disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Eicosapentaenoic acid and arachidonic acid: collaboration and not antagonism is the key to biological understanding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Neonatal polyunsaturated fatty acid metabolism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Apoptosis in schizophrenia: pathophysiologic and therapeutic considerations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings--part II.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

The role of n-3 polyunsaturated fatty acids in brain: modulation of rat brain gene expression by dietary n-3 fatty acids

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Neuroprotective effect of eicosapentaenoic acid in hippocampus of rats exposed to gamma-irradiation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Eicosapentaenoic acid confers neuroprotection in the amyloid-beta challenged aged hippocampus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Magnetic resonance spectroscopy: current and future applications in psychiatric research

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar patients and normal subjects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Apoptotic changes in the aged brain are triggered by interleukin-1beta-induced activation of p38 and reversed by treatment with eicosapentaenoic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Consensus on early intervention in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Docosahexanoic acid and omega-3 fatty acids in depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

The role of glutathione in dopaminergic neuronal survival.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time (1)H NMR spectra of the rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

MRI and neuropsychological improvement in Huntington disease following ethyl-EPA treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Ethyl-EPA in Huntington disease: a double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Temporal lobe proton magnetic resonance spectroscopy of patients with first-episode psychosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Stimulation of myelin proteolipid protein gene expression by eicosapentaenoic acid in C6 glioma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Age-dependent memory loss, synaptic pathology and altered brain plasticity in the Drosophila mutant cardinal accumulating 3-hydroxykynurenine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

In vivo magnetic resonance spectroscopy and its application to neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Role for glia in synaptogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Control of synapse number by glia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Dynamic, yet structured: The cell membrane three decades after the Singer-Nicolson model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

The effects of dietary fatty acid composition combined with environmental enrichment on brain and behavior in mice.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Brain and behavioral effects of dietary n-3 deficiency in mice: a three generational study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Effects of omega-3 fatty acid on platelet serotonin responsivity in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301628

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301628

1 reference

25 December 2017

PubMed ID

18199999

1 reference

25 December 2017